American Well Corp
AMWL5.050USD
-0.040-0.79%
Cierre 11/04, 16:00（ET）Cotizaciones retrasadas 15 min
81.25MCap. mercado
PérdidaP/E TTM
Más Datos de American Well Corp Compañía
American Well Corporation operates a hybrid care delivery enablement platform in the United States and globally, connecting providers, payers, patients and innovators. The Company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke and acute psychiatry evaluations to virtual nursing and e-sitting. For health plans, employers and government entities, its enterprise platform enables a broad set of use cases, including primary, urgent, mental health, specialty, and chronic care. Its virtual primary care solution offers a primary care navigation hub. It offers new tailored healthcare solutions for government clients that provide care options to meet the diverse needs of government healthcare systems, personnel, and their families.
Información de American Well Corp
Símbolo de cotizaciónAMWL
Nombre de la empresaAmerican Well Corp
Fecha de salida a bolsaSep 17, 2020
Director ejecutivoMr. Ido Schoenberg, M.D.
Número de empleados877
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 17
Dirección75 State Street
CiudadBOSTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal02109
Teléfono16172053500
Sitio Webhttps://business.amwell.com/
Símbolo de cotizaciónAMWL
Fecha de salida a bolsaSep 17, 2020
Director ejecutivoMr. Ido Schoenberg, M.D.
Ejecutivos de American Well Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Roy Schoenberg, M.D.
Dr. Roy Schoenberg, M.D.
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
133.30K
+23.08%
Mr. Ido Schoenberg, M.D.
Mr. Ido Schoenberg, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
114.25K
+77.82%
Dr. Peter L. Slavin, M.D.
Dr. Peter L. Slavin, M.D.
Independent Director
Independent Director
44.47K
+88.60%
Mr. Derek Ross
Mr. Derek Ross
Independent Director
Independent Director
29.49K
+242.86%
Ms. Deborah C. Jackson
Ms. Deborah C. Jackson
Independent Director
Independent Director
12.54K
-41.94%
Mr. Dmitry (Dan) Zamansky
Mr. Dmitry (Dan) Zamansky
Chief Product and Technology Officer
Chief Product and Technology Officer
2.47K
--
Dr. Delos Marshall (Toby) Cosgrove, M.D.
Dr. Delos Marshall (Toby) Cosgrove, M.D.
Independent Director
Independent Director
--
--
Mr. Mark Hirschhorn
Mr. Mark Hirschhorn
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
--
--
Ms. Phyllis I. Gotlib
Ms. Phyllis I. Gotlib
President, American Well International
President, American Well International
--
--
Ms. Rivka R. (Ricky) Goldwasser
Ms. Rivka R. (Ricky) Goldwasser
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Roy Schoenberg, M.D.
Dr. Roy Schoenberg, M.D.
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
133.30K
+23.08%
Mr. Ido Schoenberg, M.D.
Mr. Ido Schoenberg, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
114.25K
+77.82%
Dr. Peter L. Slavin, M.D.
Dr. Peter L. Slavin, M.D.
Independent Director
Independent Director
44.47K
+88.60%
Mr. Derek Ross
Mr. Derek Ross
Independent Director
Independent Director
29.49K
+242.86%
Ms. Deborah C. Jackson
Ms. Deborah C. Jackson
Independent Director
Independent Director
12.54K
-41.94%
Mr. Dmitry (Dan) Zamansky
Mr. Dmitry (Dan) Zamansky
Chief Product and Technology Officer
Chief Product and Technology Officer
2.47K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Platform Subscription
40.46M
57.07%
Visits
22.75M
32.09%
Other
7.69M
10.84%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
70.90M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Platform Subscription
40.46M
57.07%
Visits
22.75M
32.09%
Other
7.69M
10.84%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Senvest Management, LLC
9.05%
Morgan Stanley & Co. LLC
8.44%
Caledonia (Private) Investments Pty Limited
5.58%
The Vanguard Group, Inc.
4.37%
Alerce Investment Management, L.P.
3.61%
Otro
68.95%
Accionistas
Accionistas
Proporción
Senvest Management, LLC
9.05%
Morgan Stanley & Co. LLC
8.44%
Caledonia (Private) Investments Pty Limited
5.58%
The Vanguard Group, Inc.
4.37%
Alerce Investment Management, L.P.
3.61%
Otro
68.95%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
14.69%
Hedge Fund
11.93%
Research Firm
9.18%
Individual Investor
5.07%
Investment Advisor/Hedge Fund
4.45%
Private Equity
3.61%
Corporation
0.54%
Sovereign Wealth Fund
0.19%
Pension Fund
0.05%
Otro
50.31%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
291
6.40M
44.14%
-1.95M
2025Q2
331
7.42M
51.14%
-1.66M
2025Q1
349
7.29M
51.54%
-1.83M
2024Q4
358
7.65M
54.80%
-1.30M
2024Q3
371
7.45M
54.59%
-1.39M
2024Q2
383
8.06M
60.42%
-1.29M
2024Q1
405
8.42M
64.02%
-956.28K
2023Q4
418
8.05M
63.03%
-798.02K
2023Q3
431
8.26M
67.90%
-1.19M
2023Q2
440
8.42M
67.58%
-997.87K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Senvest Management, LLC
1.31M
9.05%
+4.50K
+0.34%
Jun 30, 2025
Morgan Stanley & Co. LLC
1.22M
8.44%
-1.44K
-0.12%
Jun 30, 2025
Caledonia (Private) Investments Pty Limited
808.76K
5.58%
-1.51K
-0.19%
Jun 30, 2025
The Vanguard Group, Inc.
634.30K
4.37%
+2.16K
+0.34%
Jun 30, 2025
Alerce Investment Management, L.P.
523.78K
3.61%
--
--
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
201.54K
1.39%
-4.07K
-1.98%
Jun 30, 2025
Acadian Asset Management LLC
190.59K
1.31%
+2.37K
+1.26%
Jun 30, 2025
Renaissance Technologies LLC
175.42K
1.21%
+500.00
+0.29%
Jun 30, 2025
Rock Point Advisors, LLC
173.59K
1.2%
+32.84K
+23.34%
Jun 30, 2025
Geode Capital Management, L.L.C.
147.56K
1.02%
-11.65K
-7.32%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
Global X Millennial Consumer ETF
0%
Langar Global HealthTech ETF
0%
iShares U.S. Healthcare Providers ETF
0%
ProShares UltraPro Russell2000
0%
Fidelity Digital Health ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X HealthTech ETF
0%
Schwab U.S. Broad Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Global X Russell 2000 ETF
0%
Ver más
Global X Millennial Consumer ETF
Proporción0%
Langar Global HealthTech ETF
Proporción0%
iShares U.S. Healthcare Providers ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
Fidelity Digital Health ETF
Proporción0%
Global X Russell 2000 Covered Call ETF
Proporción0%
Global X HealthTech ETF
Proporción0%
Schwab U.S. Broad Market ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Fecha
Tipo
Relación
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
